Clinical Trial Update: Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating whether anti-osteoporotic medications affect nonalcoholic fatty liver disease. The study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Osteoporosis
• Postmenopausal Osteoporosis

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal | Phase 4 | Status: ACTIVE_NOT_RECRUITING